POINT Biopharma Global Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
6.57 | 48.77 | -86.54% | -5.18 | -226.72% |
| P/S |
|
2.85 | 33.76 | -91.56% |
|
|
| P/BV |
|
1.33 | 4.82 | -72.51% |
|
|
| P/FCF |
|
5.02 | 60.98 | -91.77% |
|
|
| Ev/Ebitda |
|
2.82 | -22.12 | -112.74% |
|
|
| Ev/S |
|
1.58 | 22.56 | -92.98% |
|
|
| Ev/FCF |
|
2.1 | 68.75 | -96.94% |
|
|
| E/P |
|
0.1147 | 0.0178 | 545.34% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
56.19 | 4.83 | 1063.27% | 52.62 | 6.79% |
| ROE |
|
26.49 | 9.61 | 175.74% |
|
|
| ROA |
|
23.36 | 0.3359 | 6854.09% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
43.38 | -25.17 | -272.35% |
|
|
| ROCE |
|
25.18 | 15.33 | 64.21% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0456 | -3.67 | -101.24% | -0.0599 | -176.1% |
| Nеt Debt/Ebitda |
|
-2.25 | -3.44 | -34.58% |
|
|
| Debt/Ratio |
|
0.01 | 0.1972 | -94.91% |
|
|
| Debt/Equity |
|
0.1847 | 1.54 | -88.04% |
|
|
| Debt/Net Income |
|
0.059 | 10.31 | -99.43% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
237.39 | 43.56 | 444.91% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
1/10
|
4.16 | -56.89 | -107.31% |
| Growth impulse Ebitda 5 years |
|
-983.97 | -64.81 | 1418.24% |
| Growth impulse Net Income 5 years |
|
214557.42 | -58.33 | -367933.74% |
| Growth impulse FCF 5 years |
|
-963.54 | -47 | 1950.09% |
| Growth impulse EPS 5 years |
|
100.58 | -32.41 | -410.34% |
IP Score
6.24/10
